BoHV-4-based vector delivering Ebola virus surface glycoprotein.

Alfonso RosamiliaSarah JaccaGiulia TebaldiSilvia TibertiValentina FranceschiFrancesca MacchiSandro CaviraniGary KobingerDonald P KnowlesGaetano Donofrio

Published in: Journal of translational medicine (2016)

The BoHV-4-based vector approach described here, represents: an alternative antigen delivery system for vaccination and a proof of principle study for anti-EBOV antibodies generation in goats for potential immunotherapy applications.

Keyphrases